Navigation Links
Immune Biosimilars Will Erode $10.8 Billion in Immune Biologics Brand Sales in 2019 Across the U.S., EU5 and Japan
Date:9/23/2010

BURLINGTON, Mass., Sept. 23 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that biosimilar immune biologics will erode $10.8 billion in immune biologics brand sales in 2019 alone across the U.S., EU5 (France, Germany, Italy, Spain and United Kingdom) and Japan. According to Biosimilars Advisory Service: Physician Perspectives on Pegylated Interferon-alpha and TNF-alpha Inhibitors in Immune and Infectious Disease, competition between branded and biosimilar TNF-alpha inhibitors and pressure to reduce costs through biosimilars use will contribute to a substantial erosion of brand sales.

Biosimilars' anticipated lower costs compared with branded biologics will be a major driver of their use among both U.S. and European gastroenterologists and rheumatologists. The majority of surveyed U.S. physicians in these specialties say that a policy that reduces or eliminates out-of-pocket costs for patients would significantly or moderately increase their prescribing of biosimilars. In France and Germany, where the cost burden on patients with serious disease is minimal, surveyed gastroenterologists and rheumatologists indicate biosimilars' potential to lower costs to their institutions and clinics will be a key driver of biosimilar use.

"While sales and costs associated with immune biologics, and TNF-alpha inhibitors in particular, make these agents an attractive target for manufacturers and payers, the extent to which biosimilars are able to reduce costs may be limited because of two main factors," said Decision Resources Analyst MaryEllen Klusacek, Ph.D. "First, high development and manufacturing costs for TNF-alpha inhibitors will likely prevent biosimilars in this class from being as steeply discounted as generic small molecule therapies. Second, our primary research suggests that gastroenterologists and rheumatologists will exhibit fairly conserva
'/>"/>

SOURCE Decision Resources
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. AutoImmune Inc. Reports 2008 Second Quarter Financial Results
2. Peptimmune Presentation at Upcoming World Congress on Treatment and Research in Multiple Sclerosis
3. EUPROBIO 2008 Presentation to Highlight Latest Immune Research
4. MedImmune Presents Data at AAP National Conference & Exhibition Demonstrating Burden of RSV Disease
5. MedImmune Expands R&D Capacity with New Research Facility in Cambridge, U.K.
6. MedImmune Licenses Reverse Genetics Technology to Hungarys Omninvest for Use in Influenza Vaccine Development and Production
7. MedImmune Presents Data Highlighting its Progressive Inflammatory Disease Portfolio at the 72nd Annual Meeting of the American College of Rheumatology
8. Peptimmune Presentations at Upcoming Events
9. Protein-printing technique gives snapshots of immune system defense
10. Visualizing asthma-causing immune cells at work
11. AutoImmune Inc. Reports 2008 Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... 26, 2015 The Pittcon 2015 ... the Ernest N. Morial Convention Center in New ... of February 19, 2015) displaying products and services ... and government labs. The Exposition will offer the ... limited to, analytical chemistry; drug discovery; nanotechnology; life ...
(Date:2/26/2015)... 2015 Innovation is more urgent ... unexpected parts of the world and transforming global ... to manufacturing to health care, disruption is constantly ... and socio-political trends shake the foundations of established ... for CEOs to survive the next wave of ...
(Date:2/26/2015)... According to a new market report published by ... (Corn, Soybean, Cotton and Others), Synthetic Biology-Enabled Products and ... and Forecast, 2013 – 2019,”the global agricultural biotechnology market ... is expected to reach USD 28,694.1 million by 2019, ... 2019. , Demand for food production has increased ...
(Date:2/26/2015)... IL (PRWEB) February 26, 2015 Regis ... for the development of oncology drug substances. , Regis ... up of their new Potent Compound Suite (PCS) for ... a 36,000 square foot, cGMP facility in Morton Grove, ... cGMP manufacturing of potent compounds up to about one ...
Breaking Biology Technology:Pittcon 2015 Announces Exposition Highlights 2One Million Acts of Innovation Canada Creates Partnership with The Economist Events’ Innovation Forum 2Global Agricultural Biotechnology Market is Expected to Reach USD 28,694.1 Million in 2019 : Transparency Market Research 2Global Agricultural Biotechnology Market is Expected to Reach USD 28,694.1 Million in 2019 : Transparency Market Research 3Regis Extends cGMP Services to Oncology Market 2
... UK,s National Physical Laboratory (NPL) is working to provide more ... nanotechnology which could lead to much more accurate devices ... Nobel Prize in 1986. It uses a nano-sized probe to ... finger reading Braille on an extremely small scale. The technique ...
... 20 Deloitte today released the 2010 Technology Fast ... media, telecommunications, life sciences and clean technology companies in ... fiscal year revenue growth from 2005 to 2009.  For ... on the Technology Fast 500™ than any other single ...
... Iowa, Oct. 20 Bio-Research Products announced today ... offerings a lower cost, industrial grade for application ... Dr. Bryce Cunningham, President, said that "there has ... and pharmaceutical markets which has prompted us to ...
Cached Biology Technology:Measuring the electrical properties of nano-crystals 2Deloitte Announces 2010 Technology Fast 500™ Rankings 2Deloitte Announces 2010 Technology Fast 500™ Rankings 3Deloitte Announces 2010 Technology Fast 500™ Rankings 4Bio-Research Products Introduces New Grade of Chloroperoxidase Enzyme for Industrial Applications 2
(Date:2/5/2015)... Calif. , Jan. 27, 2015 /PRNewswire/ ... provider of globally deployed, innovative test solutions ... announced the delivery of its TS-323 ... Space Systems Company (LMSSC). GENASYS is a ... demands of mission-critical applications that require performance ...
(Date:2/5/2015)... , Feb. 3, 2015 Despite a ... from industries such as consumer electronics, automotive, storage ... surface mount technology (SMT) screen printers. Innovations in ... control will push the adoption curve up. Meanwhile, ... steady as glue dispensers are indispensable in the ...
(Date:1/22/2015)... 13, 2015 Technology Showcase, Hall E -   EyeLock ... today announced it will showcase its EyeLock ID technology integrated ... Department of Energy,s Oak Ridge National Laboratory (ORNL) ... EyeLock,s iris identity authentication technology is being used to validate ...
Breaking Biology News(10 mins):Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 3Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 4End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 2End-user Demand Spurs Global SMT Screen Printers and Glue Dispensers Market 3EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 3
... top of the marine food chain, albatrosses accumulate toxic ... bodies. A new study has found dramatic differences in ... forage in different areas of the North Pacific. Researchers ... increased in both species over the past ten years. ...
... When invaded by an infectious agent, for example, the ... and defeat the intruder. But when the biochemical processes ... turned on, inflammation can lead to adversity, including some ... closely studying the link between inflammatory processes and tumor ...
... a future in which each patient's tumor will act ... the cancer to obtain the best outcome. , ... should receive extra therapy after surgery - or whether ... does not even require surgery. Most patients with colorectal ...
Cached Biology News:Vegetables inhibit growth of prostate cancer in mice with human tumors 2Vegetables inhibit growth of prostate cancer in mice with human tumors 3Inflammation and drugs to control this activity studied in a variety of tumors sites 2Inflammation and drugs to control this activity studied in a variety of tumors sites 3Inflammation and drugs to control this activity studied in a variety of tumors sites 4Inflammation and drugs to control this activity studied in a variety of tumors sites 5Inflammation and drugs to control this activity studied in a variety of tumors sites 6Inflammation and drugs to control this activity studied in a variety of tumors sites 7Inflammation and drugs to control this activity studied in a variety of tumors sites 8Inflammation and drugs to control this activity studied in a variety of tumors sites 9AIDS-related cognitive impairment exists in two separate forms 2AIDS-related cognitive impairment exists in two separate forms 3AIDS-related cognitive impairment exists in two separate forms 4AIDS-related cognitive impairment exists in two separate forms 5AIDS-related cognitive impairment exists in two separate forms 6AIDS-related cognitive impairment exists in two separate forms 7
... introduce its new line of Protein Standards, ... for use in mass spectrometry, molecular biology, ... Standards are high quality purified proteins for ... by electrospray ionization mass spectrometry (ESI-MS). ...
... N,N- bis- (3-D-Gluconamidopropyl)deoxycholamide White ... CHAPS and CHAPSO. Has reduced electrostatic interactions ... chromatography on DEAE-cellulose. Aggregation number: 8-16. ... H 2 O. Aggregation number 8 - ...
Determine relative degree of protein binding to phosphoinositides...
Goat Anti-Horse IgG(T) Antibody, Unconjugated...
Biology Products: